Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) EBIT Margin (2022 - 2025)

Medinotec's EBIT Margin history spans 4 years, with the latest figure at 21.79% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 122.0% year-over-year to 21.79%; the TTM value through Nov 2025 reached 29.02%, up 1024.0%, while the annual FY2025 figure was 35.02%, 2306.0% up from the prior year.
  • EBIT Margin reached 21.79% in Q4 2025 per MDNC's latest filing, up from 16.33% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 55.58% in Q1 2025 to a low of 127.02% in Q3 2022.
  • Average EBIT Margin over 4 years is 1.85%, with a median of 12.94% recorded in 2023.
  • Peak YoY movement for EBIT Margin: soared 14290bps in 2023, then crashed -850bps in 2025.
  • A 4-year view of EBIT Margin shows it stood at 6.57% in 2022, then skyrocketed by 96bps to 12.88% in 2023, then soared by 60bps to 20.56% in 2024, then increased by 6bps to 21.79% in 2025.
  • Per Business Quant, the three most recent readings for MDNC's EBIT Margin are 21.79% (Q4 2025), 16.33% (Q3 2025), and 13.0% (Q2 2025).